M3 Stock Price, News & Analysis
MTHRY
OTC Link
Company Description
M3 Inc. operates globally with over 5.8 million physician members through various physician websites. The company provides services to healthcare and life science industries, including clinical research, medical education, ethical drug promotion, market research, job recruitment, and clinic appointment services. With offices in major markets such as the US, UK, Japan, S. Korea, and China, M3 Inc. is committed to serving the medical community.
Stock Performance
$7.39
-0.14%
0.01
Last updated: August 11, 2025 at 13:57
- %
Performance 1 year
$8.5B
Market Cap
1.4B
Shares outstanding
Latest News
SEC Filings
No SEC filings available for M3.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of M3 (MTHRY)?
The current stock price of M3 (MTHRY) is $7.4 as of August 8, 2025.
What is the market cap of M3 (MTHRY)?
The market cap of M3 (MTHRY) is approximately 8.5B.
What is the core business of M3 Inc.?
M3 Inc. provides services to the healthcare and life science industry, including clinical research, medical education, ethical drug promotion, market research, job recruitment, and clinic appointment services.
How many physician members does M3 Inc. have globally?
M3 Inc. operates with over 5.8 million physician members globally through various physician websites.
In which major markets does M3 Inc. have offices?
M3 Inc. has offices in major markets such as the US, UK, Japan, S. Korea, and China.
What services does M3 Inc. provide?
M3 Inc. provides services to the healthcare and life science industry, including clinical research, medical education, ethical drug promotion, market research, job recruitment, and clinic appointment services.
What is the mission of M3-Wake Research, Inc.?
M3-Wake Research's mission is to bring novel medications, biologics, and devices through clinical research to as many people as possible while providing unparalleled service and exceptional value to clinical trial partners and stakeholders.